Q4 2022 13F Holders as of 31 Dec 2022
-
Type / Class
-
Equity / Common Stock, $0.000001 par value per share
-
Shares outstanding
-
6.57M
-
Number of holders
-
74
-
Total 13F shares, excl. options
-
102M
-
Shares change
-
-17.6M
-
Total reported value, excl. options
-
$64.1M
-
Value change
-
-$83.6M
-
Put/Call ratio
-
0.24
-
Number of buys
-
39
-
Number of sells
-
-51
-
Price
-
$0.63
Significant Holders of Instil Bio, Inc. - Common Stock, $0.000001 par value per share (TIL) as of Q4 2022
107 filings reported holding TIL - Instil Bio, Inc. - Common Stock, $0.000001 par value per share as of Q4 2022.
Instil Bio, Inc. - Common Stock, $0.000001 par value per share (TIL) has 74 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 102M shares
.
Largest 10 shareholders include Curative Ventures V LLC (38M shares), Vivo Capital, LLC (12.5M shares), FMR LLC (12.3M shares), CPMG Inc (8.22M shares), BAKER BROS. ADVISORS LP (5.27M shares), BlackRock Inc. (4.74M shares), VANGUARD GROUP INC (4.16M shares), Samsara BioCapital, LLC (1.79M shares), MARSHALL WACE, LLP (1.62M shares), and STATE STREET CORP (1.29M shares).
This table shows the top 74 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.